Baseline Serum Prostate-specific Antigen Value Predicts the Risk of Subsequent Prostate Cancer Death—Results from the Norwegian Prostate Cancer ConsortiumJohan Bjerner, Jan Oldenburg, Ola Bratt et al.|European Urology|2023Cited by 13
External validation of nomograms including MRI features for the prediction of side-specific extraprostatic extensionJoris G. Heetman, Lara Franziska Stolzenbach, N. von Ostau et al.|Prostate Cancer and Prostatic Diseases|2023Cited by 10
The Changing Face of cN0M0 Prostate Cancer Being Found With pN+ After Surgery in the Contemporary Era: Results of an International European Survey on Disease ManagementMatteo Antonio Sacco, Giancarlo Marra, Giorgio Gandaglia et al.|Clinical Genitourinary Cancer|2022Cited by 3
Long-term predictive value of serum PSA values obtained in clinical practice: Results from the Norwegian Prostate Cancer Consortium (NPCC).Jan Oldenburg, Sigrid Carlsson, Johan Lars Bjerner et al.|Journal of Clinical Oncology|2022Cited by 2
Long-term predictive value of serum PSA values obtained in clinical practice – Results from the Norwegian Prostate Cancer Consortium (NPCC)Stefan Carlsson, Jan Oldenburg, Johan Bjerner et al.|European Urology|2021Cited by 0